腫瘍におけるコンパニオン診断検査の世界市場（～2026年）

• 英文タイトル：Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11453 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は腫瘍におけるコンパニオン診断検査のグローバル市場について調査・分析したレポートです。種類別（タンパク質検出、DNA検出）市場規模、用途別（製薬・バイオテクノロジー企業、医療機器企業、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍におけるコンパニオン診断検査の競争状況、市場シェア ・世界の腫瘍におけるコンパニオン診断検査市場：種類別市場規模 2015年-2020年（タンパク質検出、DNA検出） ・世界の腫瘍におけるコンパニオン診断検査市場：種類別市場規模予測 2021年-2026年（タンパク質検出、DNA検出） ・世界の腫瘍におけるコンパニオン診断検査市場：用途別市場規模 2015年-2020年（製薬・バイオテクノロジー企業、医療機器企業、研究所） ・世界の腫瘍におけるコンパニオン診断検査市場：用途別市場規模予測 2021年-2026年（製薬・バイオテクノロジー企業、医療機器企業、研究所） ・北米の腫瘍におけるコンパニオン診断検査市場分析：米国、カナダ ・ヨーロッパの腫瘍におけるコンパニオン診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍におけるコンパニオン診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍におけるコンパニオン診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍におけるコンパニオン診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Roche、Genomic Health、QIAGEN、Agilent、Agendia、BioMerieux、Illumina、Siemens Healthcare、Thermo Fisher ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Market Analysis and Insights: Global Companion Diagnostic Tests in Oncology Market
The global Companion Diagnostic Tests in Oncology market size is projected to reach US$ 4019.7 million by 2026, from US$ 3644.4 million in 2020, at a CAGR of 9.5%% during 2021-2026.

Global Companion Diagnostic Tests in Oncology Scope and Market Size
Companion Diagnostic Tests in Oncology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher

Market segment by Type, the product can be split into
Protein Detection
DNA Detection
Market segment by Application, split into
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
1.4 Market by Type
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Protein Detection
1.4.3 DNA Detection
1.5 Market by Application
1.5.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Medical Device Companies
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026)
2.2 Global Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Companion Diagnostic Tests in Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Companion Diagnostic Tests in Oncology Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size
3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
3.2.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019
3.3 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
3.4 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
3.5 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2020)
6.2 Companion Diagnostic Tests in Oncology Key Players in North America (2019-2020)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
6.4 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

7 Europe
7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2020)
7.2 Companion Diagnostic Tests in Oncology Key Players in Europe (2019-2020)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

8 China
8.1 China Companion Diagnostic Tests in Oncology Market Size (2015-2020)
8.2 Companion Diagnostic Tests in Oncology Key Players in China (2019-2020)
8.3 China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
8.4 China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

9 Japan
9.1 Japan Companion Diagnostic Tests in Oncology Market Size (2015-2020)
9.2 Companion Diagnostic Tests in Oncology Key Players in Japan (2019-2020)
9.3 Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
9.4 Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2015-2020)
10.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

11 India
11.1 India Companion Diagnostic Tests in Oncology Market Size (2015-2020)
11.2 Companion Diagnostic Tests in Oncology Key Players in India (2019-2020)
11.3 India Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
11.4 India Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Companion Diagnostic Tests in Oncology Market Size (2015-2020)
12.2 Companion Diagnostic Tests in Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
12.4 Central & South America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
13.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
13.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Genomic Health
13.3.1 Genomic Health Company Details
13.3.2 Genomic Health Business Overview
13.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
13.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.3.5 Genomic Health Recent Development
13.4 QIAGEN
13.4.1 QIAGEN Company Details
13.4.2 QIAGEN Business Overview
13.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
13.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.4.5 QIAGEN Recent Development
13.5 Agilent
13.5.1 Agilent Company Details
13.5.2 Agilent Business Overview
13.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
13.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.5.5 Agilent Recent Development
13.6 Agendia
13.6.1 Agendia Company Details
13.6.2 Agendia Business Overview
13.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
13.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.6.5 Agendia Recent Development
13.7 BioMerieux
13.7.1 BioMerieux Company Details
13.7.2 BioMerieux Business Overview
13.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
13.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.7.5 BioMerieux Recent Development
13.8 Illumina
13.8.1 Illumina Company Details
13.8.2 Illumina Business Overview
13.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
13.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.8.5 Illumina Recent Development
13.9 Siemens Healthcare
13.9.1 Siemens Healthcare Company Details
13.9.2 Siemens Healthcare Business Overview
13.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
13.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.9.5 Siemens Healthcare Recent Development
13.10 Thermo Fisher
13.10.1 Thermo Fisher Company Details
13.10.2 Thermo Fisher Business Overview
13.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
13.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
13.10.5 Thermo Fisher Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Companion Diagnostic Tests in Oncology Key Market Segments
Table 2. Key Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
Table 3. Ranking of Global Top Companion Diagnostic Tests in Oncology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Protein Detection
Table 6. Key Players of DNA Detection
Table 7. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Companion Diagnostic Tests in Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Companion Diagnostic Tests in Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2015-2020)
Table 11. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Companion Diagnostic Tests in Oncology Market Growth Strategy
Table 17. Main Points Interviewed from Key Companion Diagnostic Tests in Oncology Players
Table 18. Global Companion Diagnostic Tests in Oncology Revenue by Players (2015-2020) (Million US$)
Table 19. Global Companion Diagnostic Tests in Oncology Market Share by Players (2015-2020)
Table 20. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019)
Table 21. Global Companion Diagnostic Tests in Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
Table 24. Date of Enter into Companion Diagnostic Tests in Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2015-2020)
Table 28. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2021-2026)
Table 29. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2015-2020)
Table 30. Global Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 31. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2021-2026)
Table 32. North America Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 34. North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 35. North America Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 36. North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 37. North America Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 38. Europe Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 40. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 42. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 44. China Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 45. China Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 46. China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 47. China Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 48. China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 49. China Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 50. Japan Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 52. Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 54. Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 58. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 60. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 62. India Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 63. India Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 64. India Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 65. India Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 66. India Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 67. India Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Companion Diagnostic Tests in Oncology Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Companion Diagnostic Tests in Oncology Market Share (2019-2020)
Table 70. Central & South America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 72. Central & South America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Genomic Health Company Details
Table 85. Genomic Health Business Overview
Table 86. Genomic Health Product
Table 87. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 88. Genomic Health Recent Development
Table 89. QIAGEN Company Details
Table 90. QIAGEN Business Overview
Table 91. QIAGEN Product
Table 92. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 93. QIAGEN Recent Development
Table 94. Agilent Company Details
Table 95. Agilent Business Overview
Table 96. Agilent Product
Table 97. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 98. Agilent Recent Development
Table 99. Agendia Company Details
Table 100. Agendia Business Overview
Table 101. Agendia Product
Table 102. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 103. Agendia Recent Development
Table 104. BioMerieux Company Details
Table 105. BioMerieux Business Overview
Table 106. BioMerieux Product
Table 107. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 108. BioMerieux Recent Development
Table 109. Illumina Business Overview
Table 110. Illumina Product
Table 111. Illumina Company Details
Table 112. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 113. Illumina Recent Development
Table 114. Siemens Healthcare Company Details
Table 115. Siemens Healthcare Business Overview
Table 116. Siemens Healthcare Product
Table 117. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 118. Siemens Healthcare Recent Development
Table 119. Thermo Fisher Company Details
Table 120. Thermo Fisher Business Overview
Table 121. Thermo Fisher Product
Table 122. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (Million US$)
Table 123. Thermo Fisher Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2020 VS 2026
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Medical Device Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 9. Global Companion Diagnostic Tests in Oncology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions: 2020 VS 2026
Figure 11. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2019
Figure 14. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2019
Figure 16. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

---